Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Advancing the use of artificial intelligence in health technology assessment activities: insights and next steps from the 2025 HTAi Global Policy Forum
0
Zitationen
4
Autoren
2026
Jahr
Abstract
The use of Artificial Intelligence (AI) in Health Technology Assessment (HTA) activities presents an opportunity to enhance the efficiency, accuracy, and speed of HTA processes worldwide. However, the adoption of AI tools in HTA comes with diverse challenges and concerns that must be carefully managed to ensure their responsible, ethical, and effective deployment. The 2025 Health Technology Assessment international Global Policy Forum (GPF) informed GPF members of the integration of AI into HTA activities, with a particular focus on the use of Generative AI (GenAI). With the overarching goal of illuminating and inspiring tangible outputs and actionable recommendations, the event brought together a diverse range of interest holders to explore the opportunities and challenges of AI in HTA. This article summarizes the key discussions and themes that informed the GPF outcomes, including trust, human agency, and risk-based approaches, culminating in a proposed set of priority next steps for the HTA community regarding the integration of GenAI. It also highlights insights into the current state of digital transformation within HTA organizations and the life sciences industry, providing insights into where the field stands and where it is heading.
Ähnliche Arbeiten
Meta-analysis in clinical trials
1986 · 38.767 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 37.556 Zit.
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
2018 · 37.278 Zit.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 · 33.497 Zit.
RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · 28.429 Zit.